Rev7 loss alters cisplatin response and increases drug efficacy in chemotherapy-resistant lung cancer (Q101216732)

From Wikidata
Jump to navigation Jump to search
scientific article published on 03 November 2020
edit
Language Label Description Also known as
English
Rev7 loss alters cisplatin response and increases drug efficacy in chemotherapy-resistant lung cancer
scientific article published on 03 November 2020

    Statements

    Rev7 loss alters cisplatin response and increases drug efficacy in chemotherapy-resistant lung cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit